Follicular variant papillary thyroid carcinoma arising in struma ovarii

Endocrine Pathology

Volumn 18, Issue 3, 2007, Pages 182-186

  Boutross Tadross, Odette ^a   Saleh, Remaa ^a   Asa, Sylvia L ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

BRAF; Immunohistochemistry; Molecular diagnostics; Papillary thyroid carcinoma; ret PTC; Struma ovarii

Indexed keywords

ADULT; AGED; ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; OVARY TERATOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME; COHORT ANALYSIS; FEMALE; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PAPILLARY CARCINOMA; PATHOLOGY; RETROSPECTIVE STUDY; TERATOMA; THYROID TUMOR;

B RAF KINASE; BRAF PROTEIN, HUMAN; CYTOKERATIN 19; HBME 1 ANTIGEN; HBME-1 ANTIGEN; PROTEIN RET; RET PROTEIN, HUMAN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; KERATIN-19; MIDDLE AGED; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; RETROSPECTIVE STUDIES; STRUMA OVARII; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 39549088169     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-007-0022-8     Document Type: Article

References (23)

1. Scully R, Young R, Clement P. Tumors of the ovary, maldeveloped gonads and fallopian tubes. Atlas of tumor pathology, third series, fascicle. Washington, D.C.: Armed Forces Institute of Pathology, 1996.
2. Roth LM, Talerman A. The enigma of struma ovarii. Pathology 39(1):139-46, 2007.
3. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 12(4):333-43, 1993.
4. McDougall IR. Metastatic struma ovarii: the burden of truth. Clin Nucl Med 31(6):321-4, 2006.
5. Bolat F, Erkanli S, Kayaselcuk F, Aslan E, Tuncer I. Malignant struma ovarii: a case report. Pathol Res Pract 201(5):409-12, 2005.
6. Makani S, Kim W, Gaba AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 94(3):835-9, 2004.
7. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Path 14(4):338-42, 2001.
8. Cheung CC, Ezzat S, Ramyar L, Freeman JL, Asa SL. Molecular basis of Hurthle cell papillary thyroid carcinoma. J Clin Endocrinol Metab 85(2):878-82, 2000.
9. Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol 24(12):1622-6, 2000.
10. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28(10):1336-40, 2004.
11. Weber KB, Shroyer KR, Heinz DE, Nawaz S, Said MS, Haugen BR. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am J Clin Pathol 122(4):524-31, 2004.
12. Volante M, Bozzalla-Cassione F, DePompa R, Saggiorato E, Bartolazzi A, Orlandi F, et al. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Virchows Arch 445(2):183-8, 2004.
13. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6(4):292-306, 2006.
14. Cheung CC, Carydis B, Ezzat S, Bedard YC, Asa SL. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab 86(5):2187-90, 2001.
15. Salvatore G, Giannini R, Faviana P, Caleo A, Migliaccio A, Fagin JA, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89(10):5175-80, 2004.
16. Papotti M, Volante M, Giuliano A, Fassina A, Fusco A, Bussolati G, et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol 24(12):1615-21, 2000.
17. Schmidt JF, Heinrich M, Derr V, Corless CL, Fletcher JA, Nose V. BRAF, RAS, and RET mutations in malignant struma ovarii: a comparative study with benign struma ovarii. Mod Path 18(Suppl 1):945, 2005.
18. Flavin R, Smyth P, Crotty P, Finn S, Cahill S, Denning K, et al. BRAF T1799A mutation occurring in a case of malignant struma ovarii. Int J Surg Pathol 15(2):116-20, 2007.
19. Elisei R, Romei C, Castagna MG, Lisi S, Vivaldi A, Faviana P, et al. RET/PTC3 rearrangement and thyroid differentiation gene analysis in a struma ovarii fortuitously revealed by elevated serum thyroglobulin concentration. Thyroid 15(12):1355-61, 2005.
20. LiVolsi VA. Surgical pathology of the thyroid. Philadelphia: Saunders, 1990.
21. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs. WHO classification of tumours. Lyons, France: IARC Press, 2004.
22. DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol 893:543-8, 2003.
23. Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ. Malignant struma ovarii. Gynecol Oncol 32(2):224-7, 1989.